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Antibiotic-resistant Staphylococcus aureus is of great concern, as it causes a wide range of life-threatening infections. The cur-
rent study demonstrates that dihydropyrrolone (DHP)-coated polyacrylamide substrates are effective in reducing the number of
culturable clinical isolates of S. aureus in vitro in a dose-dependent manner and are able to reduce the pathogenic potential of
staphylococcal infection in a subcutaneous infectionmodel. Covalently bound DHPs therefore show great potential for use as an
antimicrobial strategy in device-related applications.
The rapid emergence of antibiotic-resistant Staphylococcus au-reus is of great concern in medicine due to its ability to cause a
wide range of life-threatening infections and to easily gain resis-
tance to antibiotic therapies (13, 17). For this reason, alternatives
to treat or prevent staphylococcal infections without inducing
drug resistance are needed. The use of dihydropyrrolones (DHPs)
for control of S. aureus infection is attractive, as they exhibit good
antimicrobial properties against several bacterial species, are of
low cytotoxicity toward mammalian cells (10, 11), and are also
likely to have a low propensity to induce resistance (1, 3).
Recent studies on surface attachment of a range of DHPs co-
valently attached to glass surfaces showed excellent prevention of
biofilm formation and bacterial adhesion (4). In particular,
DHP-1 demonstrated excellent broad-spectrum activity. In this
study, a polymeric substrate wasmodified by covalent attachment
of DHP-1, and the resulting material was investigated for its in
vitro and in vivo antimicrobial activity.
DHP-coated polyacrylamide beads were prepared by mixing
UltraLink biosupport medium (azlactone-functional beads;
Pierce Biotechnology, Inc., Rockford, IL) with 1,2-ethylene-
diamine solution (0.5 M in absolute ethanol). The resultant sus-
pension was vortexed and agitated at room temperature over-
night, filtered, and washed successively with absolute ethanol to
remove unreacted ethylenediamine. The amine-functional beads
were then reacted with DHP (0.03 M in ethanol), followed by use
of the same procedure described above and air drying. A sche-
matic for the reaction is shown in Fig. 1. Attachment of the DHP
to the surface was analyzed using X-ray photoelectron spectros-
copy (XPS) as described previously (4). Finally, the beads were
sterilized by exposure to 70% (wt/vol) ethanol before suspension
in 500 l sterile phosphate-buffered saline (PBS).
Successful surface modification of polyacrylamide beads was
indicated by the changes in the carbon/nitrogen (C/N) ratio and
oxygen/nitrogen (O/N) ratio, measured by XPS (Table 1). The
amine-treated beads showed a small reduction in the C/N ratio
(4.0 to 3.9) in comparison to the untreated beads, which is in
agreement with the addition of nitrogen and carbon from ethyl-
enediamine. The subsequent attachment of DHP was demon-
strated by a significant increase in the C/N ratio (3.9 to 4.6) and a
slight increase in the O/N ratio (1.1 to 1.3), signifying a higher
proportion of carbon and a small amount of oxygen from the
DHP were added to the amine-functionalized polyacrylamide
support. In addition, a fluorinated DHP (DHP-F) was also cou-
pled to the polyacrylamide support, inwhich the fluorinewas used
as a marker for XPS. Detection of fluorine on the DHP-F-coated
bead (1.5% F) and the consistent increase in the C/N and O/N
ratios further ascertain the covalent attachment of DHP on the
polyacrylamide bead.
In order to verify that DHPwas not released from thematerial,
DHP-coated beads were suspended in PBS (10 mg dry beads/ml),
with agitation for 24 h. Evaluation of the PBS solution by UV
spectrometry did not show any free DHP (data not shown).
Bacterial cultures of a clinical isolate, S. aureus strain 38 (6),
were prepared by a previously describedmethod (4) to give a final
bacterial suspension of 106 CFU/ml. This was confirmed by a ret-
rospective plate count. Equal volumes of this bacterial suspension
were added to different proportions of dry beads in PBS to final
concentrations of 0.5, 5, and 10 mg dry beads/ml, resulting in a
final bacterial suspension of 5  105 CFU/ml. The bead-bacteria
suspension was incubated on a laboratory rotator (Stuart Scien-
tific, Great Britain) at 37°C for 24 h. After this time, the beads were
allowed to settle for 20 min. The culturable bacteria in the super-
natant were quantified by plating triplicate aliquots of serial dilu-
tions onto nutrient agar plates. Plates were incubated for 24 h at
37°C, and the number of CFU was counted. Each experiment was
repeated a minimum of three times in duplicate. Statistical differ-
ences were determined by a one-way analysis of variance
(ANOVA), followed by aGames-Howell post hoc test. Results with
P values of0.05 were considered significant.
The growth of S. aureus in the presence of different propor-
tions of polyacrylamide beads was evaluated, and the results are
presented in Table 2. There was no effect of the untreated and
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amine beads, at any concentration tested, on the number of S.
aureus CFU recovered (Table 2).
ForDHP-coated beads, no significant difference in the number
of bacteria recovered from the control beads was observed at a
bead concentration of 0.5mg/ml. However, in the presence of 5 or
10 mg/ml DHP beads, a dose response was observed, with reduc-
tions in culturable bacterial counts of 4 logs (99.99%; P  0.037
and P  0.000) and 5 logs (99.999%; P  0.006 and P  0.002),
respectively, compared to those of the blank and amine-func-
tionalized controls.
Polyacrylamide beads retained after the in vitro growth studies
were spread onto nutrient agar plates without being washed. After
24 h of incubation, S. aureus growth on the untreated and amine-
treated beads was too numerous to count. In contrast, sparse bac-
terial growth and variation in colony sizes associated with the
DHP-coated beads were observed (data not shown), suggesting
that bacterial culturability was affected once the bacteria had in-
teracted with the DHP. Moreover, the supernatant suspension
and the beads were observed under fluorescence microscopy
(Olympus FV1000 confocal inverted microscope) with the aid of
LIVE/DEAD staining (data not shown). The number of bacteria in
the suspensions correlates to the number of bacteria obtained
from retrospective counting. Very few bacteria were observed
around theDHPbeads as opposed to the control beads, indicating
that the bacteria were not adhered to the DHP beads.
Themechanisms of action of DHP are believed to be similar to
those reported for fimbrolides and furanones, acting as bacterial
quorum-sensing (QS) inhibitors by interacting with the
membrane-associated surface proteins of bacterial cells (9, 12, 16).
In addition, N-acylhomoserine lactones (AHLs) and furanones
have been shown to affect the biofilm formation and growth of S.
aureus, and it has been suggested that this is mediated by interfer-
ence with the QS systems sarA and agr (15). Previous in vivo study
has demonstrated activity for covalently attached furanones (5);
however, the precise mechanism has not yet been confirmed. To-
gether, these findings imply that the interaction betweenDHP and
bacteria occurs on the surface of the cells, which indirectly affects
the cell replication of the bacteriumormay have rendered the cells
viable but nonculturable (8, 14). Similar behavior of S. aureuswas
observed when the bacterium was grown in the presence of silver
nanoparticles, in which the growth is affected due to a prolonged
bacterial lag phase (7).
To examine the effects ofDHP surface coating in vivo, S. aureus
strain 38 prepared as described above was adjusted to 106 CFU/ml
in PBS and then mixed with polyacrylamide beads (DHP-treated
beads or controls) to a final bead concentration of 5mg dry beads/
ml. The mixture of bacteria and beads in a total volume of 200 l
was injected subcutaneously into the shaved flanks of five 8-week-
old male BALB/c mice per treatment. The mice were monitored
for 4 days. Clinical parameters were scored on a scale of 0 to 4, for
which 0 meant no pathology and 4 meant severe redness and
swelling. All protocols for animal use were approved by the insti-
tutional animal ethics committee. Experimentswere performed in
triplicate. Statistical differences were determined by a nonpara-
metric Mann-Whitney test. Results with P values of 0.05 were
considered significant.
For the groups injected with untreated or amine-func-
tionalized beads, the lesions showed a significant increase of 2- to
3-fold over those injected with the DHP beads (P  0.036 and
0.001, respectively) in the average clinical score by day 2. Further
increases in gross pathology in all controlmicewere observed over
the subsequent days (days 3 and 4) (Fig. 2A andB). In contrast, the
group injected with DHP-coated beads showed no significant
change in gross clinical observations throughout the monitoring
period (Fig. 2C).
At day 4, mice were euthanized, and the beads and tissue asso-
TABLE 2 Numbers of culturable S. aureus CFU/ml after 24 h of growth




No. of CFU/ml with indicated proportions (mg/ml) of beadsa
0.5 5 10
Untreated 4.8 108 7.8 107 4.2 108 5.6 107 4.3 108 1.5 107
Amine 4.9 108 2.5 107 5.1 108 3.1 107 5.0 108 3.7 107
DHP 4.0 108 4.6 107 1.7 104 1.4 103b 3.0 103 6.6 102b
a Results reexpressed as the numbers of CFU/ml standard derivations of the means.
b Significant differences to the same quantity of untreated beads (P 0.05).
FIG 1 Schematic of the attachment chemistry. Azlactone groups on the polyacrylamide beads were first ring opened with ethylenediamine, followed by reaction
with DHP.




C/N ratio O/N ratioC N O F
Untreated 65.3 16.2 18.5 4.0 1.1
Amine 64.5 16.6 18.9 3.9 1.1
DHP 66.9 14.6 18.6 4.6 1.3
DHP-F 65.3 14.3 18.9 1.5 4.6 1.3
a C, carbon; O, oxygen; N, nitrogen; F, fluorine.
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ciated with them at the injection site were collected and homoge-
nized in 1 ml of PBS. Culturable bacteria were quantified by serial
dilution and plate counting, as described above. Bacterial num-
bers recovered in the presence of untreated or amine-treated
beads were not significantly different (P  0.284) (Fig. 2D) and
were consistent with findings in other models (2). However, bac-
terial numbers recovered from theDHP-coated bead sites showed
a significant, approximately 2-log reduction in bacterial numbers
compared to those from both the blank and amine-functionalized
surfaces (P  0.03 and 0.048, respectively) (Fig. 2D), with no
morphotypic variants in the bacterial colonies.
There was an apparent reduction in inhibitory activity of the
DHP in the animal model compared to the in vitro data. This
could be due to effects of deposition of host biomolecules such as
proteins and lipids onto the surface of the beads, whichmay partly
block the ability of the DHP to interact with the bacteria.
In vivo results suggest that DHP-coated polyacrylamide beads
are able to reduce the gross pathology and reduce the bacterial
load in a subcutaneous S. aureus infectionmodel. Importantly, the
DHP-coated beads did not cause any apparent adverse effect on
the mice and therefore appear to be biocompatible. The reduced
virulence may be an effect of quorum-sensing inhibition, as the
quorum-sensing signal N-3-oxo-dode-anoyl-L-homoserine lac-
tone (3-oxo-C12-HSL) was found to inhibit exotoxin production
in S. aureus (15), and DHP, having effects similar to those of
3-oxo-C12-HSL on the growth of S. aureus, is believed to interfere
with the same pathway.
This study is the first to demonstrate the efficacy of surface-
attached antibacterial DHP in vivo. The present study shows that
DHP-coated polyacrylamide beads are effective against staphylo-
coccal infections in vivo and shows great potential for prevention
of infection in topical and device-related applications.
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